Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
Abstract Percutaneous and surgical therapies for septal reduction for hypertrophic cardiomyopathy have been going head‐to‐head for the past 20 years with similar outcomes and mortality rates, although contemporary myectomy seems to materialize its superiority. However, on closer analysis, the extern...
Main Authors: | Alexandru Achim, Adela Mihaela Serban, Stefan Dan Cezar Mot, Gregor Leibundgut, Madalin Marc, Ulrich Sigwart |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.14272 |
Similar Items
-
Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy
by: Sergei A. Budagaev, et al.
Published: (2023-07-01) -
Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
by: Victor Arévalos, et al.
Published: (2021-05-01) -
Surgical septal myectomy versus septal alcohol ablation for hypertrophic obstructive cardiomyopathy: a continuing debate
by: S Meditskou, et al.
Published: (2008-05-01) -
Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
by: Ibadete Bytyçi, et al.
Published: (2020-09-01) -
Endocardial septal ablation for hypertrophic obstructive cardiomyopathy
by: Tolga Aksu, et al.
Published: (2017-01-01)